Sign In
Dr. Andrew Zolopa, MD
About ProfilePoints™
0 Patient Reviews

Dr. Andrew Zolopa, MD

Infectious Disease Specialist - General

Highlights

  • Board Certified
  • Accepts Insurance Plans

Biography

Dr. Andrew Zolopa, MD is a Infectious Disease Specialist - General practicing in Stanford, CA

He has not yet shared a personalized biography with Doctor.com.

View Phone #Call Now

Are you Dr. Andrew Zolopa, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

InstitutionFocusYear
Internship - Santa Clara Vly Medical CtrNot Specified

CertificationCert. BodyYear
Internal medicineInternal MedicineNot Specified

Experience & Accolades

Publication Publisher Title Published
Other PublicationClinical infectious diseasesLow Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral2013
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESA Randomized Double-Blind Comparison of Coformulated2013
Other PublicationAIDSTest performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS2013
Other PublicationJOURL OF GENE MEDICINEPatient monitoring and follow-up in lentiviral clinical trials2013
Other PublicationJOURL OF INFECTIOUS DISEASESElevated Interleukin 8 and T-Helper 1 and T2012
Other PublicationCurrent HIV/AIDS reportsWhen to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!2012
Other PublicationLANCETCo-formulated elvitegravir2012
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYStandardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase2012
Other PublicationPLOS ONEAssociation of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults2011
Other PublicationCLINICAL INFECTIOUS DISEASESBlood (1 -> 3)-beta-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia2011
Other PublicationAIDSCost-effectiveness of antiretroviral regimens in the World Health Organization's treatment2011
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESInflammation and Mortality in HIV-Infected Adults: Alysis of the FRAM Study Cohort2010
Other PublicationCLINICAL INFECTIOUS DISEASESConcerns Regarding a R2010
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYHIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance2010
Other PublicationHIV CLINICAL TRIALSEarly Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections2010
Other PublicationCURRENT OPINION IN INVESTIGATIOL DRUGSOptimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance2010
Other PublicationPLOS ONERisk Factor Alyses for Immune Reconstitution Inflammatory Syndrome in a R2010
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYPredicting Tipravir and Daruvir Resistance Using Genotypic, Phenotypic2010
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYIntertiol Cohort Alysis of the Antiviral Activities of Zidovudine2010
Other PublicationJOURL OF INFECTIOUS DISEASESActivity of Elvitegravir, a Once-Daily Integrase Inhibitor2010
Other PublicationAIDSDevelopment of a didanosene genotypic resistance interpretation system based on large derivation2010
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESAssociation of HIV Infection2010
Other PublicationANTIVIRAL RESEARCHThe evolution of HIV treatment guidelines: Current state-of-the-art of ART2010
Other PublicationJOURL OF CLINICAL VIROLOGYSwitch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients2009
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYNonpolymorphic Human Immunodeficiency Virus Type 1 Protease2009
Other PublicationCURRENT OPINION IN HIV AND AIDSThe use of resistance testing in the magement of HIV-1-infected patients2009
Other PublicationPLOS ONEEarly Antiretroviral Therapy Reduces AIDS Progression2009
Other PublicationCurrent HIV/AIDS reportsInitiation of antiretroviral therapy in the hospitalized patient with an acute AIDS2009
Other PublicationCLINICAL INFECTIOUS DISEASESMaintaining Reduced Viral Fitness2009
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESHepatotoxicity and Gastrointestil Intolerance When Healthy Volunteers Taking Rifampin Add Twice2009
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYSafety and Efficacy of Enfuvirtide in Combition with Daruvir2008
Other PublicationAMERICAN JOURL OF CLINICAL NUTRITIONEvaluation of high-protein supplementation in weight2008
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYVirologic Response to Lopivir-Ritovir2008
Other PublicationJOURL OF INFECTIOUS DISEASESInitiatives for developing and comparing genotype interpretation systems2008
Other PublicationJourl of HIV therapyIntegrase inhibitors: a clinical review of raltegravir and elvitegravir.2008
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYEffect of concomitantly administered rifampin on the pharmacokinetics2007
Other PublicationJOURL OF INFECTIOUS DISEASESPhase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor2007
Other PublicationJOURL OF INFECTIOUS DISEASESA randomized, partially blinded phase 2 trial of antiretroviral therapy2006
Other PublicationAIDS RESEARCH AND HUMAN RETROVIRUSESN88D facilitates the co2006
Other PublicationJOURL OF INFECTIOUS DISEASESIncorporating drug-resistance measurements into the clinical magement of HIV-1 infection2006
Other PublicationAMERICAN JOURL OF EPIDEMIOLOGYThe study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design2006
Other PublicationQUALITY OF LIFE RESEARCHThe effect of diagnosis with HIV infection on health-related quality of life2006
Other PublicationMedGenMed : Medscape general medicineCase files from Stanford University Medical Center2006
Other PublicationCLINICAL PHARMACOLOGY & THERAPEUTICSPharmacokinetic interactions between indivir plus ritovir and calcium channel blockers2005
Other PublicationJOURL OF INFECTIOUS DISEASESHIV-1 protease and reverse-transcriptase mutations2005
Other PublicationCLINICAL INFECTIOUS DISEASESAntiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection2005
Other PublicationCLINICAL INFECTIOUS DISEASESAccuracy, precision, and consistency of expert HIV type 1 genotype interpretation2005
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESDetection of minority populations of HIV2005
Other PublicationINTERTIOL JOURL OF STD & AIDSPrevalence of antiretroviral drug resistance in the HIV-12004
Other PublicationANTIVIRAL THERAPYClinically validated genotype alysis: guiding principles and statistical concerns2004
Other PublicationAIDSHigh levels of adherence do not prevent accumulation of HIV drug resistance mutations2003
Other PublicationJOURL OF INFECTIOUS DISEASESLack of detectable human immunodeficiency virus type 1 superinfection during 1072 person2003
Other PublicationAIDSExtended spectrum of HIV2003
Other PublicationJOURL OF VIROLOGYMutation patterns and structural correlates in human immunodeficiency virus type 1 protease2003
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYVirtual inhibitory quotient predicts response to ritovir boosting of indivir2002
Other PublicationJAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESSubtle decreases in stavudine phenotypic susceptibility predict poor virologic response to2002
Other PublicationANTIMICROBIAL AGENTS AND CHEMOTHERAPYEvolution of primary protease inhibitor resistance mutations during protease inhibitor salvage2002
Other PublicationJOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESCharacterization of the HIV2001
Other PublicationAIDS clinical careHIV drug resistance testing: an update for the clinician.2001
Other PublicationJOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESGenotypic correlates of a virologic response to stavudine after zidovudine monotherapy2001
Other PublicationAIDSNon-adherence to highly active antiretroviral therapy predicts progression to AIDS2001
Other PublicationAIDSPhenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment2001
Other PublicationJOURL OF CLINICAL MICROBIOLOGYHigh degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease2001
Other PublicationAIDS RESEARCH AND HUMAN RETROVIRUSESHighly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes2000
Other PublicationARCHIVES OF INTERL MEDICINEAdherence to isoniazid prophylaxis in the homeless - A randomized controlled trial2000
Other PublicationAIDSAdherence to protease inhibitors, HIV-1 viral load2000
Other PublicationANTIVIRAL THERAPYThe relation between baseline HIV drug resistance and response to antiretroviral therapy2000
Other PublicationJOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMESEfavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients2000
Other PublicationANLS OF INTERL MEDICINEHIV-1 genotypic resistance patterns predict response to saquivir1999
Other PublicationCLINICAL INFECTIOUS DISEASESInvasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS1999
Other PublicationLawrence, J., Schapiro, J., Winters, M., Montoya, J., Zolopa, A., PesaClinical resistance patterns1999
Other PublicationJOURL OF COMMUNITY HEALTHAssociation between time homeless and perceived health status among the homeless in San Francisco1997
Other PublicationAIDSPREVALENCE OF MEASLES ANTIBODIES IN ADULTS WITH HIV-INFECTION1992

Practice & Hospital Affiliations

Dr. Andrew Zolopa, MD has not yet indicated the hospitals that he is affiliated with.

Photos

Provider Profile 0

Specialties

Languages Spoken
English
Medical Specialties
  • Infectious Disease Specialist

Years In Practice: 20 (started in 2005)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.
I Accept